Clinical Trial Update: Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab in combination with mFOLFOX-6 for colorectal cancer with liver metastases; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: UNKNOWN